Abstract
Trypanosoma cruzi (T. cruzi) infection is endemic in Latin America.1 T. cruzi can be transmitted to human beings through the feces of a kissing bug, congenitally, blood transfusion, oral transmission, laboratory contamination, and organ transplantation.1 In 14–30% of patients, acute T. cruzi infection is followed by a long, clinically silent period before the clinical presentation of chronic Chagas’ disease (CD). The T. cruzi infection may result in heterogeneous heart (H) phenotypes, including bradycardia; right bundle-branch block, left anterior fascicular block; cardiomyopathy; heart failure (HF), thromboembolism; arrhythmias; sudden death; and syncope.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.